ADVERTISEMENT
Divi’s Labs Vying For No. 2 Spot Among India’s Generics-Dominated Pharma Stocks
Founded 29 years ago by Murali Divi, his bet on the high-margin chemicals that go into making medicines more than paid off.
21 Jan 2020, 02:55 PM IST
When the U.S. drug regulator effectively barred exports from Divi’s Laboratories Ltd.’s biggest facility in Visakhapatnam in March 2017, the maker of pharma raw materials wiped off half of its value in five months.The U.S. Food and Drug Administration cited improper controls, falsified or poor documentation and R&D that was inconsistent with good manufacturing practices for the import alert for Visakhapatnam Unit 2 that contributes 7...
I’m already a Subscriber Sign In
To continue reading this story
Subscribe to unlock & enjoy all Members-only benefits
Choose a plan
Renews automatically. Cancel anytime.
As a Subscriber you get
Access to
Stories
Curated
Newsletters
20,000+
Research Reports
Priority Pass
to Special Events
Ad-Lite
Experience
Members-Only
Rewards
NDTV Profit
Exclusive Stories
Full Access to
NDTV Profit App
Access to
Stories
20,000+
Research Reports
Ad-Lite
Experience
NDTV Profit
Exclusive Stories
Curated
Newsletters
Priority Pass
to Special Events
Members-Only
Rewards
Full Access to
NDTV Profit App
Still Not convinced ? Know More
Get live Stock market updates, Business news, Today’s latest news, Trending stories, and Videos on NDTV Profit.
ADVERTISEMENT